Failure to Satisfy Listing Rule (Form 8-K)

As previously disclosed on January 21, 2026, The Nasdaq Stock Market LLC ("Nasdaq") notified Nexalin Technology, Inc. (the "Company") that the bid price of its common stock had closed at less than $1.00 per share over the previous 30 consecutive business days and, as a result, the Company did not comply with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market (the "Minimum Bid Price Requirement"). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided 180 calendar days, or until July 20, 2026, to regain compliance with the Minimum Bid Price Requirement.

On July 24, 2026, the Company received a Staff Determination letter from Nasdaq (the "Delisting Notice") stating that the Company has not regained compliance with the Minimum Bid Price Requirement and is not eligible for a second 180-day compliance period because the Company does not comply with the $5,000,000 minimum stockholders' equity initial listing requirement for The Nasdaq Capital Market. Accordingly, Nasdaq has determined that the Company's securities will be scheduled for delisting from The Nasdaq Capital Market and will be suspended at the opening of business on August 4, 2026, and a Form 25-NSE will be filed with the Securities and Exchange Commission to remove the Company's securities from listing and registration on The Nasdaq Stock Market, unless the Company requests an appeal of this determination.

The Company may appeal Nasdaq's determination to a Nasdaq Hearings Panel (the "Panel") pursuant to the procedures set forth in Nasdaq Listing Rule 5800 Series. A hearing request must be submitted no later than 4:00 p.m. Eastern Time on July 31, 2026. A hearing request will stay the suspension of the Company's securities and the filing of the Form 25-NSE pending the Panel's decision. The Company will be asked to provide a plan to regain compliance to the Panel, which may include a discussion of the events the Company believes will enable it to regain compliance and a commitment to effect a reverse stock split, if necessary.

The Company has timely requested a hearing before the Panel to appeal Nasdaq's determination. There can be no assurance that the Panel will grant the Company's request for continued listing or that the Company will be able to regain compliance with the applicable Nasdaq listing requirements.